These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16544914)

  • 1. Continuous release of Rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage forms.
    Mohl S; Winter G
    Pharm Dev Technol; 2006 Feb; 11(1):103-10. PubMed ID: 16544914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms controlling protein release from lipidic implants: effects of PEG addition.
    Herrmann S; Winter G; Mohl S; Siepmann F; Siepmann J
    J Control Release; 2007 Apr; 118(2):161-8. PubMed ID: 17275943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous release of rh-interferon alpha-2a from triglyceride matrices.
    Mohl S; Winter G
    J Control Release; 2004 May; 97(1):67-78. PubMed ID: 15147805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIR spectroscopy-a non-destructive analytical tool for protein quantification within lipid implants.
    Schönbrodt T; Mohl S; Winter G; Reich G
    J Control Release; 2006 Aug; 114(2):261-7. PubMed ID: 16872710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants.
    Herrmann S; Mohl S; Siepmann F; Siepmann J; Winter G
    Pharm Res; 2007 Aug; 24(8):1527-37. PubMed ID: 17380261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
    Schulze S; Winter G
    J Control Release; 2009 Mar; 134(3):177-85. PubMed ID: 19121347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ precipitation and vacuum drying of interferon alpha-2a: development of a single-step process for obtaining dry, stable protein formulation.
    Kumar V; Sharma VK; Kalonia DS
    Int J Pharm; 2009 Jan; 366(1-2):88-98. PubMed ID: 18824225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
    Kasper JC; Troiber C; Küchler S; Wagner E; Friess W
    Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12).
    Ressing ME; Jiskoot W; Talsma H; van Ingen CW; Beuvery EC; Crommelin DJ
    Pharm Res; 1992 Feb; 9(2):266-70. PubMed ID: 1372732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of storage on the dissolution rate of a fast-dissolving perphenazine/β-cyclodextrin complex.
    Turunen E; Korhonen O; Lehto VP; Kauppinen A; Ahtiainen H; Järvinen K; Jarho P
    J Pharm Pharmacol; 2014 Mar; 66(3):367-77. PubMed ID: 24206258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes.
    van den Hoven JM; Metselaar JM; Storm G; Beijnen JH; Nuijen B
    Int J Pharm; 2012 Nov; 438(1-2):209-16. PubMed ID: 22960501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of formulation technique for hydroxypropyl-beta-cyclodextrin on the stability of aspirin in HFA 134a.
    Williams RO; Liu J
    Eur J Pharm Biopharm; 1999 Mar; 47(2):145-52. PubMed ID: 10234539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.
    Ramezani V; Vatanara A; Seyedabadi M; Nabi Meibodi M; Fanaei H
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1103-1111. PubMed ID: 28276783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-beta-cyclodextrin.
    Scalia S; Tursilli R; Sala N; Iannuccelli V
    Int J Pharm; 2006 Aug; 320(1-2):79-85. PubMed ID: 16713145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
    Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
    Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: development of a novel process for obtaining a dry, stable powder.
    Sharma VK; Kalonia DS
    AAPS PharmSci; 2004 Jan; 6(1):E4. PubMed ID: 15198505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin.
    Ruiz L; Reyes N; Duany L; Franco A; Aroche K; Hardy Rando E
    Int J Pharm; 2003 Oct; 264(1-2):57-72. PubMed ID: 12972336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real time stability and viability prediction of the anticancer BCG after lyophilization.
    Mohamed D; Elsayed I; Mohamed AF; Yehia SA
    Drug Dev Ind Pharm; 2015; 41(11):1769-76. PubMed ID: 25652359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of in vivo and in vitro release data for rh-INFalpha lipid implants.
    Schwab M; Kessler B; Wolf E; Jordan G; Mohl S; Winter G
    Eur J Pharm Biopharm; 2008 Oct; 70(2):690-4. PubMed ID: 18582576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.